4/22
08:03 am
crdl
Cardiol Therapeutics Inc. (NASDAQ: CRDL) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $9.00 price target on the stock.
Medium
Report
Cardiol Therapeutics Inc. (NASDAQ: CRDL) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $9.00 price target on the stock.
4/2
06:12 am
crdl
Cardiol Therapeutics Announces Year-End 2023 Update on Operations [Yahoo! Finance]
Medium
Report
Cardiol Therapeutics Announces Year-End 2023 Update on Operations [Yahoo! Finance]
2/21
07:45 am
crdl
Cardiol Therapeutics Completes Patient Enrollment in its Phase II MAvERIC-Pilot Study Investigating CardiolRx(TM) for Recurrent Pericarditis [Yahoo! Finance]
Medium
Report
Cardiol Therapeutics Completes Patient Enrollment in its Phase II MAvERIC-Pilot Study Investigating CardiolRx(TM) for Recurrent Pericarditis [Yahoo! Finance]
2/15
07:45 am
crdl
Cardiol Therapeutics Granted Orphan Drug Designation for its Lead Drug Candidate for the Treatment of Pericarditis [Yahoo! Finance]
High
Report
Cardiol Therapeutics Granted Orphan Drug Designation for its Lead Drug Candidate for the Treatment of Pericarditis [Yahoo! Finance]